| Literature DB >> 27195489 |
April D Davis1, Shannon M D Morgan1,2, Michelle Dupuis1, Craig E Poulliott1, Jodie A Jarvis1, Rhianna Franchini1,3, Anne Clobridge1, Robert J Rudd1.
Abstract
Silver-haired bats, (Lasionycteris noctivagans) are semi-colonial, migratory tree bats that have infrequent contact with humans. Despite the species rarity, the L. noctivagans rabies variant is the most commonly reported rabies virus variant (RABV) in domestically acquired human rabies cases in the US. Unlike big brown bats (Eptesicus fuscus) and little brown bats (Myotis lucifugus), L. noctivagans are not considered true hibernators. It is unknown if RABV can overwinter in hibernating L. noctivagans or is only maintained in members of this taxa that migrate to warmer climates. To better understand RABV overwintering in this species, L. noctivagans were inoculated intramuscularly with either a homologous RABV (L. noctivagans Virus 1) or one of two heterologous RABV (Eptesicus fuscus Virus 2 and Myotis lucifugus Virus 1). Five days following inoculation, L. noctivagans were placed in a hibernation chamber for 6 weeks. Our results demonstrate that rabies virus can overwinter in L. noctivagans yet the incubation period was extended 6 weeks when compared to bats maintained at ambient temperatures. Additionally, we found that the longer the incubation period, the greater the viral dissemination to the salivary glands. Similar to our previous studies, L. noctivagans were most susceptible to a homologous variant. In summary, we found that RABV incubation is extended following a subcutaneous exposure or maintenance in hibernation and longer incubation times increase dissemination and potential for transmission.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27195489 PMCID: PMC4873251 DOI: 10.1371/journal.pone.0155542
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Bats maintained in hibernation for 6 weeks.
Serological and survival results of L. noctivagans inoculated with homologous or heterologous RABV via SC or IM inoculation. Regardless of the virus or route, the titer of inoculum was 104TCID50.
| Bat group and no. | Virus/ route | Incubation time (dpi) | Incubation time following arousal | qPCR results for oral swabs (dpi) | Ct value of oral swab | Status of bat | Infecting Variant | Rabies virus titer VNA (IU/ml) days post primary inoculation primary inoc | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Group 1 | LnV1/IM | Pre inoc | 14 days post hibernation | 30 days post hibernation | 45 days post challenge | ||||||
| 1 | N | A | ≤LOD | ≤LOD | 2.0 | ≤LOD | |||||
| 2 | 50 | 27(18) | P (45) | 29 | D | LnV1 | ≤LOD | 0.525 | 2.0 | ||
| 3 | 66 | 19(42) | N | >40 | D | LnV1 | ≤LOD | 4.0 | |||
| 4 | 80 | 33 (42) | P (71) | 29 | D | LnV1 | ≤LOD | ≤LOD | ≤LOD | ||
| 5 | N | A | ≤LOD | ≤LOD | ≤LOD | ≤LOD | |||||
| Group 2 | EfV2/IM | ||||||||||
| 6 | N | A | ≤LOD | ND | >9.6 IU | 6.2 | |||||
| 7 | N | A | ≤LOD | ≤LOD | ≤LOD | ≤LOD | |||||
| 8 | 137 | 90(42) | P (136) | 30 | D | EfV2 | ≤LOD | ≤LOD | >16 IU | ||
| 9 | N | A | ≤LOD | ≤LOD | 2.8 | 8.8 | |||||
| 10 | N | A | ≤LOD | ≤LOD | ≤LOD | 1.7 | |||||
| Group 3 | MlV1/IM | ||||||||||
| 11 | 70 | 23 (42) | N | >40 | D | MlV1 | ≤LOD | ≤LOD | ≤LOD | ||
| 12 | N | A | ≤LOD | ≤LOD | ≤LOD | 3.1 | |||||
| 13 | N | A | ≤LOD | ≤LOD | ≤LOD | 4.6 | |||||
| 14 | N | A | ≤LOD | 8.3 | 4 | ≤LOD | |||||
| 15 | N | A | ≤LOD | ≤LOD | ≤LOD | ≤LOD | |||||
ND Not done; serum sample was inadequate for testing
a Days post inoculation
b Negative or positive (dpi oral swabs were positive)
c The survival status of the bat is denoted A for alive and D for deceased
d Bats were bled prior to rabies inoculation
e Days post challenge. Bats were challenged 9 mo following the first inoculation
f≤LOD = Below the limit of detection
g denotes terminal bleed
h This bat was caught more than 150 days before clinical signs developed. Site of inoculation unknown
i. Ct values >40 are considered negative
Bats maintained at ambient temperature.
Serological and survival results of L. noctivagans inoculated with homologous or heterologous RABV via SC or IM inoculation. Regardless of the virus or route, the titer of inoculum was 104TCID50.
| Bat group and n | Virus/route | Incubation time (dpi) | qPCR results for oral swabs (dpi) | Ct value of oral swab | Status of bat | Infecting Variant | Rabies virus titer VNA (IU/ml) days post primary inoculation | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Group 1 | LnV1/IM | Pre inoc | 90dpi | 60 dpc | 180dpc | |||||
| 16 | N | A | ≤LOD | ≤LOD | ND | ≤LOD | ||||
| 17 | 22 | N | >40 | D | LnV1 | ≤LOD | ≤LOD | |||
| 18 | N | A | ≤LOD | ≤LOD | ND | ≤LOD | ||||
| 19 | 20 | N | >40 | D | LnV1 | ≤LOD | ≤LOD | |||
| 20 | 14 | N | >40 | D | LnV1 | ≤LOD | 1.0 | |||
| Group 2 | LnV1/SQ | |||||||||
| 21 | N | A | ≤LOD | ≤LOD | ≤LOD | ≤LOD | ||||
| 22 | 33 | P (30) | 32 | D | LnV1 | ≤LOD | 0.25 | |||
| 23 | N | A | ≤LOD | ≤LOD | ≤LOD | ≤LOD | ||||
| 24 | 14 | P (14) | 31 | D | LnV1 | ≤LOD | 2.0 | |||
| 25 | N | A | ≤LOD | ≤LOD | ND | |||||
| Group 3 | EfV2/IM | |||||||||
| 26 | N | A | ≤LOD | ≤LOD | ≤LOD | ≤LOD | ||||
| 27 | N | A | ≤LOD | ≤LOD | ≤LOD | ≤LOD | ||||
| 28 | N | A | ≤LOD | 1.3 | ≤LOD | ≤LOD | ||||
| 29 | N | A | ≤LOD | 2.1 | 0.5 | 0.5 | ||||
| 30 | N | A | ≤LOD | ≤LOD | ≤LOD | ≤LOD | ||||
| Group 4 | EfV2/SC | |||||||||
| 31 | N | A | ≤LOD | 5.0 | 1.2 | 0.8 | ||||
| 32 | 33 | P (29,32) | 28,28 | D | EfV2 | ≤LOD | 0.25 | |||
| 33 | N | A | ≤LOD | 1.0 | 3.4 | 0.45 | ||||
| 34 | N | A | ≤LOD | ≤LOD | ND | ND | ||||
| 35 | 37 | P (37) | 31 | D | EfV2 | ≤LOD | ≤LOD | |||
| Group 5 | MlV1/IM | |||||||||
| 36 | N | A | ≤LOD | ≤LOD | ≤LOD | ≤LOD | ||||
| 37 | ≥150 | N | >40 | D | LnV1 | ≤LOD | 1.25 | |||
| 38 | N | A | ≤LOD | ≤LOD | 0.3 | ≤LOD | ||||
| 39 | N | A | ≤LOD | ≤LOD | ND | ≤LOD | ||||
| 40 | N | A | ≤LOD | 2.0 | ≤LOD | ≤LOD | ||||
| Group 6 | MlV1/SC | |||||||||
| 41 | N | A | ≤LOD | ≤LOD | ND | 0.38 | ||||
| 42 | N | A | ≤LOD | 2.6 | ND | ≤LOD | ||||
| 43 | N | A | ≤LOD | ≤LOD | ≤LOD | 1.4 | ||||
| 44 | N | A | ≤LOD | ≤LOD | 2.6 | 3.15 | ||||
| 45 | N | A | ≤LOD | ≤LOD | ≤LOD | ≤LOD | ||||
ND Not done; serum sample was inadequate for testing
a Days post inoculation
b Negative or positive (dpi oral swabs were positive)
c The survival status of the bat is denoted A for alive and D for deceased
d Bats were bled prior to rabies inoculation
e Days post challenge. Bats were challenged 9 mo following the first inoculation
f≤LOD = Below the limit of detection
g denotes terminal bleed
h This bat was caught more than 150 days before clinical signs developed. Site of inoculation unknown
i. Ct values >40 are considered negative
Dissemination of Rabies virus RNA evaluated by real time RT-PCR in hibernated bats.
Data is provided as Ct values.
| Bat ID | 2 | 3 | 4 | 8 | 11 | |
| Infecting variant/Route | LnV1/IM | LnV1/IM | LnV1/IM | EfV2/IM | MlV1/IM | |
| Days in hibernation | 18 | 42 | 42 | 42 | 42 | |
| Days at ambient temps following hibernation | 27 | 19 | 33 | 90 | 23 | No of positive specimens/total no tested (%) |
| Total incubation period dpi | 50 | 66 | 80 | 137 | 70 | |
| Tissue | ||||||
| SG | 28.3 | <LOD | 28.5 | 21.8 | <LOD | 3/5 (60%) |
| Nose | 31.7 | 35 | 33.4 | 29.0 | 35.5 | 5/5 (100%) |
| Tongue | 29.3 | <LOD | 33.4 | 28.3 | <LOD | 3/5 (60%) |
| Diaphragm | 34.3 | <LOD | <LOD | 27.3 | <LOD | 2/5 (40%) |
| Bladder | 30.0 | <LOD | <LOD | 27.8 | <LOD | 2/5 (40%) |
| R. B plexus | 28.3 | 27.8 | 26.4 | 18.3 | 27.4 | 5/5 (100%) |
| L.B plexus | 26.4 | <LOD | 33.6 | 20.0 | 27.8 | 4/5 (80%) |
| R Sciatic N | 30.3 | 33.6 | 31.1 | 28.5 | 32 | 5/5 (100%) |
| L. Sciatic N | 31.0 | <LOD | 29.6 | 23.9 | 32 | 4/5 (80%) |
| GI | 29.6 | <LOD | 28.9 | 23.7 | <LOD | 3/5 (60%) |
| Anterior SC | 17.6 | 22.5 | 20.7 | 17.2 | 16.9 | 5/5 (100%) |
| Posterior SC | 27.8 | 33.5 | 25.1 | 28.5 | 24.8 | 5/5 (100%) |
| Buccal tissue | <LOD | <LOD | 32.8 | 26.1 | <LOD | 3/5 (60%) |
| Inoculation site, muscle | 31.7 | 30.7 | 23.9 | 30.7 | <LOD | 4/5 (80%) |
| Skin superficial to inoculation site | 31.8 | <LOD | <LOD | 26.9 | 26.9 | 3/5 (60%) |
| Brown fat | 17.6 | 36.6 | 30.0 | 17.2 | 30.0 | 5/5 (100%) |
| White back fat | 29.6 | 34.5 | 39.6 | 28.5 | <LOD | 4/5 (80%) |
| Number of RV positive tissues / total tissues (%) +itive | 16/17 (94%) | 8/17 (47%) | 14/17 (82%) | 17/17 (100%) | 9/17 (53%) | |
a SG, Salivary glands; B plexus, Brachial plexus; R, Right; L, left; N, Nerve GI, Gastrointestinal; SC, Spinal cord
b LOD, results are below the limit of detection for our test
Dissemination of Rabies virus RNA in bats maintained at ambient temperature, as evaluated by real time-rtPCR. Data is provided as Ct values.
| Bat ID no. (infecting variant, route of inoculation, and days post inoculation) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Bat ID | Ln37 | Ln 17 | Ln 19 | Ln 20 | Ln 22 | Ln 24 | Ln 32 | Ln 35 | |
| Infecting variant/route | LnV1 | Ln/IM | LnV1/IM | LnV1/IM | LnV1/SC | LnV1/SC | LnV1/SC | LnV1/SC | |
| Incubation: days post inoculation | >150 | 22 | 20 | 14 | 14 | 33 | 33 | 37 | |
| Tissue | No of positive specimens/total no tested (%) | ||||||||
| SG | 17.0 | ≤LOD | ≤LOD | ≤LOD | 27.1 | 32 | 28.0 | 27.4 | 5/8 (63%) |
| Nose | 29.3 | 34 | ≤LOD | ≤LOD | 30.6 | 34 | 33.4 | 34.9 | 6/8 (75%) |
| Tongue | 30.00 | 31 | ≤LOD | ≤LOD | ≤LOD | ≤LOD | 29.8 | 31.5 | 4/8 (50%) |
| Lung | 26.8 | 30 | ≤LOD | ≤LOD | 26.9 | 37.0 | 30.1 | 29.0 | 6/8 (75%) |
| Diaphragm | 26.4 | 31 | ≤LOD | 30.9 | ≤LOD | 32.4 | 28.4 | 30.3 | 6/8 (75%) |
| R. B plexus | 22.4 | 25 | 27 | 24.5 | 25.7 | 24.6 | 28.4 | 25.7 | 8/8 (100%) |
| L. B plexus | 28.3 | 26 | 29 | 31.0 | 26.8 | 26.9 | 24.0 | 25.9 | 8/8 (100%) |
| R. Sciatic N | 24.3 | 30 | 37 | 31.6 | 26.6 | 29.7 | 28.8 | 28.2 | 8/8 (100%) |
| L. Sciatic N | ≤LOD | 28 | ≤LOD | ≤LOD | 30.1 | 27.6 | 29.0 | 32.0 | 5/8 (63%) |
| GI | 19.3 | 28 | ≤LOD | ≤LOD | 26.9 | ND | 33.5 | 39.3 | 5/8 (63%) |
| Anterior SC | 17.9 | 21 | 21 | 19.3 | 19.3 | 19.1 | 20.6 | 18.3 | 8/8 (100%) |
| Posterior SC | 21.0 | 25 | ≤LOD | 30.3 | 21.7 | 34.0 | 30.4 | 24.4 | 7/8 (88%) |
| Buccal tissue | 34.4 | 31 | ≤LOD | ≤LOD | 32.3 | ≤LOD | 33.0 | 27.4 | 5/8 (63%) |
| Nuchal skin | 26.8 | 27 | 28 | 32.4 | 34.7 | 24.8 | 25.7 | 24.5 | 8/8 (100%) |
| Inoculation site, muscle | 28 | 30 | ≤LOD | ≤LOD | 28.8 | 26.7 | 30.3 | 5/7 (71%) | |
| Inoculation site, skin | 32 | 27 | ≤LOD | 32.9 | 35.4 | 27.7 | 31.5 | 6/7 (86%) | |
| Spleen | 33.0 | 31 | ≤LOD | ≤LOD | 31.8 | ND | ≤LOD | 30.4 | 4/7 (57%) |
| Brown fat | 16.0 | ≤LOD | ≤LOD | 32.4 | 25.7 | 30.5 | 21.9 | 29.0 | 6/8 (75%) |
| White fat | 25.8 | 31.3 | ≤LOD | ≤LOD | ≤LOD | ≤LOD | 30.6 | 26.5 | 4/8 (50%) |
| No. of positive tissues/total no. tested (%) | 16/17 (94%) | 17/19 (89%) | 7/19 (37%) | 8/19 (42%) | 15/19 (79%) | 14/17 (82%) | 18/19 (95%) | 19/19 (100%) | |
a SG, Salivary glands; B plexus, Brachial plexus; R, Right; L, Left. N, Nerve; GI, Gastrointestinal; SC, Spinal cord
b This bat was caught150 days or more before clinical signs developed. Site of inoculation unknown
c LOD, results are below the limit of detection for our test
d Tissues not available for testing
Fig 1Weight changes in rabies inoculated bats following hibernation.
Weight loss in hibernated bats inoculated with: A. LnV1. Bats 2, 3, and 4 developed rabies. B. EfV2. Bat 8 developed rabies. C. MlV1. Bat 11 developed rabies. * Denotes day 42. D. Percent weight change (grams) in non-inoculated control bats. E Percent weight change (grams) over the 6 week hibernation period.
Fig 2Single factor ANOVA of daily individual weight average grouped by cage reveals no variation in weight dependent on cage location.